Literature DB >> 23108406

A tumor suppressor role for srGAP3 in mammary epithelial cells.

A Lahoz1, A Hall.   

Abstract

srGAP3, a member of the Slit-Robo sub-family of Rho GTPase-activating proteins (Rho GAPs), controls actin and microtubule dynamics through negative regulation of Rac. Here, we describe a potential role for srGAP3 as a tumor suppressor in mammary epithelial cells. We show that RNAi-mediated depletion of srGAP3 promotes Rac dependent, anchorage-independent growth of partially transformed human mammary epithelial cells (HMECs). Furthermore, srGAP3 expression is absent, or significantly reduced in 7/10 breast cancer cell lines compared with normal HMECs. Re-expression of srGAP3 in a subset of these cell lines inhibits both anchorage-independent growth and cell invasion in a GAP-dependent manner, and this is accompanied by an increase in phosphorylation of the ezrin/radixin/moesin (ERM) family proteins and myosin light chain 2 (MLC2). Inhibition of the Rho regulated kinase, ROCK, reduces ERM and MLC2 phosphorylation and restores invasion. We conclude that srGAP3 has tumor suppressor-like activity in HMECs, likely through its activity as a negative regulator of Rac1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23108406     DOI: 10.1038/onc.2012.489

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  Identifying Candidate Druggable Targets in Canine Cancer Cell Lines Using Whole-Exome Sequencing.

Authors:  Sunetra Das; Rupa Idate; Kathryn E Cronise; Daniel L Gustafson; Dawn L Duval
Journal:  Mol Cancer Ther       Date:  2019-06-07       Impact factor: 6.261

Review 2.  The Rac GTPase in Cancer: From Old Concepts to New Paradigms.

Authors:  Marcelo G Kazanietz; Maria J Caloca
Journal:  Cancer Res       Date:  2017-08-14       Impact factor: 12.701

Review 3.  Mind the (sr)GAP - roles of Slit-Robo GAPs in neurons, brains and beyond.

Authors:  Bethany Lucas; Jeff Hardin
Journal:  J Cell Sci       Date:  2017-11-02       Impact factor: 5.285

4.  SLIT2/ROBO2 signaling pathway inhibits nonmuscle myosin IIA activity and destabilizes kidney podocyte adhesion.

Authors:  Xueping Fan; Hongying Yang; Sudhir Kumar; Kathleen E Tumelty; Anna Pisarek-Horowitz; Hila Milo Rasouly; Richa Sharma; Stefanie Chan; Edyta Tyminski; Michael Shamashkin; Mostafa Belghasem; Joel M Henderson; Anthony J Coyle; David J Salant; Stephen P Berasi; Weining Lu
Journal:  JCI Insight       Date:  2016-11-17

Review 5.  Targeting Cdc42 in cancer.

Authors:  Luis E Arias-Romero; Jonathan Chernoff
Journal:  Expert Opin Ther Targets       Date:  2013-08-19       Impact factor: 6.902

Review 6.  The emerging roles of srGAPs in cancer.

Authors:  Vaishali Ji; Chandra Kishore
Journal:  Mol Biol Rep       Date:  2021-11-25       Impact factor: 2.316

Review 7.  Fixing the GAP: The role of RhoGAPs in cancer.

Authors:  Gabriel Kreider-Letterman; Nicole M Carr; Rafael Garcia-Mata
Journal:  Eur J Cell Biol       Date:  2022-02-10       Impact factor: 6.020

Review 8.  Slit/Robo pathway: a promising therapeutic target for cancer.

Authors:  Rishi K Gara; Sonam Kumari; Aditya Ganju; Murali M Yallapu; Meena Jaggi; Subhash C Chauhan
Journal:  Drug Discov Today       Date:  2014-09-20       Impact factor: 7.851

9.  Neat1 is a p53-inducible lincRNA essential for transformation suppression.

Authors:  Stephano S Mello; Carolyn Sinow; Nitin Raj; Pawel K Mazur; Kathryn Bieging-Rolett; Daniela Kenzelmann Broz; Jamie F Conklin Imam; Hannes Vogel; Laura D Wood; Julien Sage; Tetsuro Hirose; Shinichi Nakagawa; John Rinn; Laura D Attardi
Journal:  Genes Dev       Date:  2017-07-11       Impact factor: 11.361

Review 10.  The emerging role of Slit-Robo pathway in gastric and other gastro intestinal cancers.

Authors:  Tingting Huang; Wei Kang; Alfred S L Cheng; Jun Yu; Ka Fai To
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.